XERIS BIOPHARMA HOLDINGS, INC. Subsidiaries
Every subsidiary the company listed in Exhibit 21 of its annual reports, newest list first (5 lists). Names and jurisdictions are as filed.
- 2026-03-02: Subsidiary Xeris Pharmaceuticals, Inc.; Jurisdiction Delaware.
- 2026-03-02: Subsidiary Xeris Pharmaceuticals Australia Pty Ltd; Jurisdiction Australia.
- 2026-03-02: Subsidiary Strongbridge Biopharma Limited; Jurisdiction Ireland.
- 2026-03-02: Subsidiary Strongbridge Dublin Limited; Jurisdiction Ireland.
| Annual report filed | Subsidiary | Jurisdiction |
|---|---|---|
| 2026-03-02 | Xeris Pharmaceuticals, Inc. | Delaware |
| 2026-03-02 | Xeris Pharmaceuticals Australia Pty Ltd | Australia |
| 2026-03-02 | Strongbridge Biopharma Limited | Ireland |
| 2026-03-02 | Strongbridge Dublin Limited | Ireland |
| 2026-03-02 | Cortendo AB | Sweden |
| 2025-03-06 | Xeris Pharmaceuticals, Inc. | Delaware |
| 2025-03-06 | Xeris Pharmaceuticals Australia Pty Ltd | Australia |
| 2025-03-06 | Strongbridge Biopharma Limited | Ireland |
| 2025-03-06 | Strongbridge Dublin Limited | Ireland |
| 2025-03-06 | Cortendo AB | Sweden |
| 2024-03-06 | Xeris Pharmaceuticals, Inc. | Delaware |
| 2024-03-06 | Xeris Pharmaceuticals Australia Pty Ltd | Australia |
| 2024-03-06 | Strongbridge Biopharma Limited | Ireland |
| 2024-03-06 | Strongbridge Dublin Limited | Ireland |
| 2024-03-06 | Cortendo AB | Sweden |
| 2023-03-08 | Xeris Pharmaceuticals, Inc. | Delaware |
| 2023-03-08 | Xeris Pharmaceuticals Australia Pty Ltd | Australia |
| 2023-03-08 | Strongbridge Biopharma Limited | Ireland |
| 2023-03-08 | Strongbridge Dublin Limited | Ireland |
| 2023-03-08 | Cortendo AB | Sweden |
| 2022-03-11 | Xeris Pharmaceuticals, Inc. | Delaware |
| 2022-03-11 | Xeris Pharmaceuticals Australia Pty Ltd | Australia |
| 2022-03-11 | Strongbridge Biopharma Limited | Ireland |
| 2022-03-11 | Strongbridge Dublin Limited | Ireland |
| 2022-03-11 | Cortendo AB | Sweden |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |